Product Name :
Rigosertib (ON-01910, Estybon)
Description:
Rigosertib (ON-01910,Estybon) is a potent, specific PLK1 inhibitor with IC50 value of 9nM. Rigosertib strongly inhibited the proliferation of cancer cell lines, with observed IC50 values in the nanomolar range for both HeLa (115 nM) and C33A (45 nM) cells. In contrast, rigosertib had a minimal effect on normal cell lines, BJ and Ect1/E6E7 (IC50 > 0.1 mM) HeLa and C33A cells demonstrated a complete (>95%) G2/M arrest at concentrations of rigosertib >0.5 μM, whereas at <0.2 μM no clear perturbation of the cell cycle was evident. Normal cells were less affected by rigosertib . Rigosertib has been reported to be a more potent radiosensitizer than cisplatin in vivo .
CAS:
1225497-78-8
Molecular Weight:
473.47
Formula:
C21H24NNaO8S
Chemical Name:
sodium 2-[(2-methoxy-5-{[2-(2,4,6-trimethoxyphenyl)ethenesulfonyl]methyl}phenyl)amino]acetate
Smiles :
[Na+].COC1C=C(OC)C(C=CS(=O)(=O)CC2C=CC(OC)=C(C=2)NCC([O-])=O)=C(C=1)OC
InChiKey:
VLQLUZFVFXYXQE-USRGLUTNSA-M
InChi :
InChI=1S/C21H25NO8S.Na/c1-27-15-10-19(29-3)16(20(11-15)30-4)7-8-31(25,26)13-14-5-6-18(28-2)17(9-14)22-12-21(23)24;/h5-11,22H,12-13H2,1-4H3,(H,23,24);/q;+1/p-1/b8-7+;
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{Salbutamol} site|{Salbutamol} Adrenergic Receptor|{Salbutamol} Technical Information|{Salbutamol} References|{Salbutamol} manufacturer|{Salbutamol} Epigenetics}
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Rigosertib (ON-01910,Estybon) is a potent, specific PLK1 inhibitor with IC50 value of 9nM. Rigosertib strongly inhibited the proliferation of cancer cell lines, with observed IC50 values in the nanomolar range for both HeLa (115 nM) and C33A (45 nM) cells. In contrast, rigosertib had a minimal effect on normal cell lines, BJ and Ect1/E6E7 (IC50 > 0.{{Evinacumab} medchemexpress|{Evinacumab} Others|{Evinacumab} Purity & Documentation|{Evinacumab} Purity|{Evinacumab} custom synthesis|{Evinacumab} Autophagy} 1 mM) HeLa and C33A cells demonstrated a complete (>95%) G2/M arrest at concentrations of rigosertib >0.PMID:23329319 5 μM, whereas at Product information|CAS Number: 1225497-78-8|Molecular Weight: 473.47|Formula: C21H24NNaO8S|Chemical Name: sodium 2-[(2-methoxy-5-{[2-(2,4,6-trimethoxyphenyl)ethenesulfonyl]methyl}phenyl)amino]acetate|Smiles: [Na+].COC1C=C(OC)C(C=CS(=O)(=O)CC2C=CC(OC)=C(C=2)NCC([O-])=O)=C(C=1)OC|InChiKey: VLQLUZFVFXYXQE-USRGLUTNSA-M|InChi: InChI=1S/C21H25NO8S.Na/c1-27-15-10-19(29-3)16(20(11-15)30-4)7-8-31(25,26)13-14-5-6-18(28-2)17(9-14)22-12-21(23)24;/h5-11,22H,12-13H2,1-4H3,(H,23,24);/q;+1/p-1/b8-7+;|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|Products are for research use only. Not for human use.|